• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

稠合嘧啶的抗癌和抗菌活性:最新进展

Anticancer and Antibacterial Activeness of Fused Pyrimidines: Newfangled Updates.

作者信息

Bhatnagar Ayushi, Pemawat Gangotri

机构信息

Department of Chemistry, University College of Science, Mohanlal Sukhadia University, Udaipur, Rajasthan, India 313001.

Department of Chemistry, University College of Science, Mohanlal Sukhadia University, Udaipur, Rajasthan, India 313001.

出版信息

Bioorg Chem. 2024 Dec;153:107780. doi: 10.1016/j.bioorg.2024.107780. Epub 2024 Sep 3.

DOI:10.1016/j.bioorg.2024.107780
PMID:39260159
Abstract

Pyrimidine-based heterocyclic compounds are garnering substantial interest due to their essential role as a class of natural and synthetic molecules. These compounds show a diverse array of biologically relevant activities, making them highly prospective candidates for clinical translation as therapeutic agents in combating various diseases. Pyrimidine derivatives and their fused analogues, such as thienopyrimidines, pyrazolopyrimidines, pyridopyrimidines, and pyrimidopyrimidines, hold immense possibility in both anticancer and antibacterial research. These compounds exhibit notable efficacy by targeting protein kinases, which are crucial enzymes regulating fundamental cellular processes like metabolism, migration, division, and growth. Through enzyme inhibition, these derivatives disrupt key cellular signaling pathways, thereby affecting critical cellular functions and viability. The advantage lies in the ubiquity of the pyrimidine structure across various natural compounds, enabling interactions with enzymes, genetic material, and cellular components pivotal for chemical and biological processes. This interaction plays a central role in modulating vital biological activities, making pyrimidine-containing compounds indispensable in drug discovery. In the realm of anticancer therapy, these compounds strategically target key proteins like EGFR, important for aberrant cell growth. Fused pyrimidine motifs, exemplified by various drugs, are designed to inhibit EGFR, thereby impeding tumor progression. Moreover, these compounds influence potent antibacterial activity, interfering with microbial growth through mechanisms ranging from DNA replication inhibition to other vital cellular functions. This dual activity, targeting both cancer cells and microbial pathogens, underscores the versatility and potential of pyrimidine derivatives in medical applications. This review provides insights into the structural characteristics, synthesis methods, and significant medicinal applications of fused pyrimidine derivatives, highlighting their double role in combating cancer and bacterial infections.

摘要

基于嘧啶的杂环化合物因其作为一类天然和合成分子的重要作用而备受关注。这些化合物展现出一系列与生物学相关的多样活性,使其成为作为治疗剂对抗各种疾病进行临床转化的极具前景的候选物。嘧啶衍生物及其稠合类似物,如噻吩并嘧啶、吡唑并嘧啶、吡啶并嘧啶和嘧啶并嘧啶,在抗癌和抗菌研究中具有巨大潜力。这些化合物通过靶向蛋白激酶展现出显著疗效,蛋白激酶是调节诸如代谢、迁移、分裂和生长等基本细胞过程的关键酶。通过酶抑制,这些衍生物破坏关键的细胞信号通路,从而影响关键的细胞功能和活力。优势在于嘧啶结构在各种天然化合物中普遍存在,能够与对化学和生物过程至关重要的酶、遗传物质和细胞成分相互作用。这种相互作用在调节重要生物活性中起核心作用,使得含嘧啶化合物在药物发现中不可或缺。在抗癌治疗领域,这些化合物战略性地靶向如EGFR等对异常细胞生长重要的关键蛋白。以各种药物为例的稠合嘧啶基序旨在抑制EGFR,从而阻碍肿瘤进展。此外,这些化合物具有强大的抗菌活性,通过从抑制DNA复制到其他重要细胞功能的多种机制干扰微生物生长。这种针对癌细胞和微生物病原体的双重活性凸显了嘧啶衍生物在医学应用中的多功能性和潜力。本综述深入探讨了稠合嘧啶衍生物的结构特征、合成方法和重要的药用应用,强调了它们在对抗癌症和细菌感染中的双重作用。

相似文献

1
Anticancer and Antibacterial Activeness of Fused Pyrimidines: Newfangled Updates.稠合嘧啶的抗癌和抗菌活性:最新进展
Bioorg Chem. 2024 Dec;153:107780. doi: 10.1016/j.bioorg.2024.107780. Epub 2024 Sep 3.
2
Thienopyrimidine: Unveiling the Versatile Potential of a Promising Heterocyclic Scaffold in Drug Discovery.噻吩并嘧啶:揭示一种有前景的杂环骨架在药物发现中的多功能潜力。
Chem Biol Drug Des. 2025 Jun;105(6):e70146. doi: 10.1111/cbdd.70146.
3
Therapeutic potential of anticancer activity of nitrogen-containing heterocyclic scaffolds as Janus kinase (JAK) inhibitor: Biological activity, selectivity, and structure-activity relationship.含氮杂环类作为 Janus 激酶(JAK)抑制剂的抗癌活性的治疗潜力:生物活性、选择性和构效关系。
Bioorg Chem. 2024 Nov;152:107696. doi: 10.1016/j.bioorg.2024.107696. Epub 2024 Aug 8.
4
Advances in the Synthesis and SAR of Pyrido[2,3-]pyrimidine Scaffold.吡啶并[2,3 - ]嘧啶骨架的合成与构效关系研究进展
Curr Pharm Des. 2025;31(19):1521-1536. doi: 10.2174/0113816128338087241217072045.
5
Identification of indole-grafted pyrazolopyrimidine and pyrazolopyridine derivatives as new anti-cancer agents: Synthesis, biological assessments, and molecular modeling insights.吲哚接枝的吡唑并嘧啶和吡唑并吡啶衍生物作为新型抗癌剂的鉴定:合成、生物学评估及分子模拟见解
Bioorg Chem. 2024 Dec;153:107804. doi: 10.1016/j.bioorg.2024.107804. Epub 2024 Sep 6.
6
The nucleobase analog 4-thiouracil hijacks the pyrimidine salvage pathway to inhibit growth.核碱基类似物4-硫尿嘧啶利用嘧啶补救途径来抑制生长。
Microbiol Spectr. 2025 Jul;13(7):e0064025. doi: 10.1128/spectrum.00640-25. Epub 2025 May 27.
7
Identification of Compounds With Potential Dual Inhibitory Activity Against Drug Efflux Pumps in Resistant Cancer Cells and Bacteria: Protocol for a Systematic Review.鉴定对耐药癌细胞和细菌中的药物外排泵具有潜在双重抑制活性的化合物:系统评价方案
JMIR Res Protoc. 2025 Jun 5;14:e66197. doi: 10.2196/66197.
8
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
9
A systematic review on natural products with antimicrobial potential against WHO's priority pathogens.关于对世界卫生组织重点病原体具有抗菌潜力的天然产物的系统评价。
Eur J Med Res. 2025 Jul 1;30(1):525. doi: 10.1186/s40001-025-02717-x.
10
Unveiling the Therapeutic Potential of Compounds Carrying Mono- and Bis-Thiazole Nuclei with Distinct Heterocyclic Analogues for Addressing Cancer Challenges.揭示带有单噻唑和双噻唑核以及不同杂环类似物的化合物在应对癌症挑战方面的治疗潜力。
Curr Cancer Drug Targets. 2025 Jun 20. doi: 10.2174/0115680096375796250610065705.

引用本文的文献

1
Structure-based design, synthesis, computational screening and biological evaluation of novel pyrrole fused pyrimidine derivatives targeting InhA enzyme.基于结构的新型吡咯并嘧啶衍生物的设计、合成、计算筛选及针对InhA酶的生物学评价,该衍生物靶向InhA酶。
RSC Adv. 2025 Jul 21;15(32):25776-25798. doi: 10.1039/d5ra03004h.